发明名称 |
Compounds and methods for treating aberrant adrenocartical cell disorders |
摘要 |
Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing’ s syndrome and/or pituitary adrenocorticotropic hormone (ACTH) excess (Cushing’ s Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N’-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient. |
申请公布号 |
NZ630828(A) |
申请公布日期 |
2016.10.28 |
申请号 |
NZ20130630828 |
申请日期 |
2013.03.13 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF MICHIGAN;MILLENDO THERAPEUTICS INC. |
发明人 |
HAMMER GARY;KERPPOLA TOM;KERPPOLA RAILI |
分类号 |
A61K31/17;A61K35/00;A61P5/38 |
主分类号 |
A61K31/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|